New Clinical Rehabilitation Approach for the Management of Falls Risks
Launched by UNIVERSITÉ DU QUÉBEC À CHICOUTIMI · Dec 8, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help prevent falls in older adults, especially those with conditions that affect their muscles and bones, like Parkinson's disease or chronic back pain. Falls are a big concern for older people because they can lead to serious injuries and even death. The goal of this research is to create a better rehabilitation program that can help these individuals improve their balance and strength, ultimately reducing the risk of falls.
To participate in the trial, you need to be 65 years or older and either currently receiving rehabilitation at La Baie Hospital or on the waiting list for geriatric services. You should be able to perform exercises and tests to help assess your risk of falling. Throughout the trial, participants will go through several phases, including evaluations of their physical abilities, participating in a specific exercise program aimed at preventing falls, and providing feedback about their experiences. This program not only aims to improve health outcomes for older adults but also hopes to reduce healthcare costs related to fall-related injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to La Baie Hospital rehabilitation services; or
- • Admitted to the waiting list for geriatric services at La Baie Hospital; or
- • Older adults from the communityé
- • Age 65 and over
- • Able-bodied adult with minimal autonomy to perform fall-prevention tests and exercises.
- • Have at least one neuro-musculo-skeletal disorders and risk of falls
- Exclusion Criteria:
- • Cancer
- • Red flags (infection, tumor, etc.)
- • Severe psychiatric disorders
- • Palliative care
- • Congenital spinal deformity (spondylolysis, intervertebral fusions)
- • Severe systemic syndromes or diseases that may prevent tests and exercises from being performed.
- • Stroke - very acute phase (1 week) and this until medial hemodynamic stability.
About Université Du Québec à Chicoutimi
Université du Québec à Chicoutimi (UQAC) is a leading academic institution dedicated to advancing research and innovation in the health sciences. With a strong commitment to community engagement and interdisciplinary collaboration, UQAC conducts clinical trials that aim to improve patient outcomes and contribute to the broader medical knowledge base. The university's research initiatives are supported by a team of experienced professionals who prioritize ethical standards and scientific rigor, ensuring that all studies are designed to meet the highest standards of safety and efficacy. Through its clinical trial sponsorship, UQAC seeks to foster advancements in healthcare and promote the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saguenay, Quebec, Canada
Patients applied
Trial Officials
Sharlène Côté, MD
Study Chair
CIUSSS-SLSJ (La Baie Hospital)
Julie Bouchard, PhD
Study Director
Université du Québec à Chicoutimi
Patrice Tremblay, PT
Study Chair
CIUSSS-SLSJ (La Baie Hospital)
Rubens da Silva
Principal Investigator
Université du Québec à Chicoutimi
Marie-Ève Langelier, MD
Study Chair
Université du Québec à Chicoutimi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported